Weil's Disease—Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota
Leptospirosis is an important zoonotic disease, causing about 60,000 deaths annually. In
this review, we have described in detail the immunopathogenesis of leptospirosis, the …
this review, we have described in detail the immunopathogenesis of leptospirosis, the …
A dual pharmacological strategy against COVID-19: The therapeutic potential of metformin and atorvastatin
LA De Jesús-González, RM Del Ángel… - Microorganisms, 2024 - mdpi.com
Metformin (MET) and atorvastatin (ATO) are promising treatments for COVID-19. This review
explores the potential of MET and ATO, commonly prescribed for diabetes and dyslipidemia …
explores the potential of MET and ATO, commonly prescribed for diabetes and dyslipidemia …
Metformin therapy changes gut microbiota alpha-diversity in COVID-19 patients with type 2 diabetes: the role of SARS-CoV-2 variants and antibiotic treatment
The gut microbiota play a crucial role in maintaining host health and have a significant
impact on human health and disease. In this study, we investigated the alpha diversity of gut …
impact on human health and disease. In this study, we investigated the alpha diversity of gut …
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study
This study investigates the intricate interplay between Metabolic-associated Fatty Liver
Disease (MAFLD) and COVID-19, exploring the impact of MAFLD on disease severity …
Disease (MAFLD) and COVID-19, exploring the impact of MAFLD on disease severity …
Metformin Alters mRNA Expression of FOXP3, RORC, and TBX21 and Modulates Gut Microbiota in COVID-19 Patients with Type 2 Diabetes
COVID-19 remains a significant global concern, particularly for individuals with type 2
diabetes who face an elevated risk of hospitalization and mortality. Metformin, a primary …
diabetes who face an elevated risk of hospitalization and mortality. Metformin, a primary …